NasdaqCM - Nasdaq Real Time Price USD

The Beauty Health Company (SKIN)

Compare
1.6650
+0.0450
+(2.78%)
As of 9:52:20 AM EST. Market Open.

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 78.8M
Earnings -18.3M
Q4'23
Q1'24
Q2'24
Q3'24
0
20M
40M
60M
80M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

1.00 Low
1.72 Average
1.6650 Current
2.00 High

Earnings Estimate

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts 2--21
Avg. Estimate -0.090-0.09-0.17
Low Estimate -0.130-0.1-0.17
High Estimate -0.050-0.08-0.17
Year Ago EPS 0.01--0.17-0.09

Revenue Estimate

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts 7689
Avg. Estimate 77.76M76.81M328.35M338.58M
Low Estimate 74.8M69.2M325.6M289.6M
High Estimate 81.01M81.16M331.81M372M
Year Ago Sales 96.8M81.4M398M328.35M
Sales Growth (year/est) -19.67%-5.64%-17.50%3.12%

Earnings History

Currency in USD 12/31/2023 3/31/2024 6/30/2024 9/30/2024
EPS Est. -0.07-0.080.01-0.05
EPS Actual 0.010.050.080.04
Difference 0.080.130.070.09
Surprise % 115.21%167.60%717.00%196.67%

EPS Trend

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Current Estimate -0.090-0.09-0.17
7 Days Ago -0.010-0.03-0.03
30 Days Ago -0.010-0.030.1
60 Days Ago -0.010-0.030.05
90 Days Ago -0.010-0.030.05

EPS Revisions

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
SKIN -925.69%---153.60%-88.89%
S&P 500 8.39%11.26%13.82%13.53%

Upgrades & Downgrades

Maintains Canaccord Genuity: Hold to Hold 11/13/2024
Maintains Canaccord Genuity: Hold to Hold 8/12/2024
Reiterates Piper Sandler: Underweight to Underweight 8/9/2024
Maintains Stifel: Hold to Hold 7/26/2024
Maintains Piper Sandler: Underweight to Underweight 7/11/2024
Maintains DA Davidson: Buy to Buy 5/13/2024

Related Tickers